Shoulder Options seeks to divest its AFT™ Proximal Humerus Fracture, AFT™ Greater Tuberosity Fracture and CRP™ Cuff Repair plates.
The FDA-cleared systems have been granted U.S. utility and design patents, and the portfolio includes what is reported to be the first device designed specifically for treatment of greater tuberosity fractures of the proximal humerus bone, as well as the first fixable suture anchor plate on the market.
Additional details for the systems are available online.
Sources: Shoulder Options, Inc.; ORTHOWORLD Inc.
Shoulder Options seeks to divest its AFT™ Proximal Humerus Fracture, AFT™ Greater Tuberosity Fracture and CRP™ Cuff Repair plates.
The FDA-cleared systems have been granted U.S. utility and design patents, and the portfolio includes what is reported to be the first device designed specifically for treatment of greater...
Shoulder Options seeks to divest its AFT™ Proximal Humerus Fracture, AFT™ Greater Tuberosity Fracture and CRP™ Cuff Repair plates.
The FDA-cleared systems have been granted U.S. utility and design patents, and the portfolio includes what is reported to be the first device designed specifically for treatment of greater tuberosity fractures of the proximal humerus bone, as well as the first fixable suture anchor plate on the market.
Additional details for the systems are available online.
Sources: Shoulder Options, Inc.; ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.